BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 31360013)

  • 1. Incompatible crossmatch: First sign of a hemolytic transfusion reaction due to out-of-group platelet transfusion.
    Basu D; Basu S; Roy J; Reddy M; Chandy M; Bhaumik J
    Asian J Transfus Sci; 2019; 13(1):57-59. PubMed ID: 31360013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Easier said than done: ABO compatibility and D matching in apheresis platelet transfusions.
    Dunbar NM; Katus MC; Freeman CM; Szczepiorkowski ZM
    Transfusion; 2015 Aug; 55(8):1882-8. PubMed ID: 25757728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current trends in platelet transfusions practice: The role of ABO-RhD and human leukocyte antigen incompatibility.
    Valsami S; Dimitroulis D; Gialeraki A; Chimonidou M; Politou M
    Asian J Transfus Sci; 2015; 9(2):117-23. PubMed ID: 26420927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Posttransfusion platelet count increments after ABO-compatible versus ABO-incompatible platelet transfusions in noncancer patients: an observational study.
    Pavenski K; Warkentin TE; Shen H; Liu Y; Heddle NM
    Transfusion; 2010 Jul; 50(7):1552-60. PubMed ID: 20210928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of changes in hemoglobin levels associated with ABO-incompatible plasma in apheresis platelets.
    Mair B; Benson K
    Transfusion; 1998 Jan; 38(1):51-5. PubMed ID: 9482394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ABO antibody titers are not predictive of hemolytic reactions due to plasma-incompatible platelet transfusions.
    Karafin MS; Blagg L; Tobian AA; King KE; Ness PM; Savage WJ
    Transfusion; 2012 Oct; 52(10):2087-93. PubMed ID: 22339320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABO-mismatched platelet transfusions: strategies to mitigate patient exposure to naturally occurring hemolytic antibodies.
    Josephson CD; Castillejo MI; Grima K; Hillyer CD
    Transfus Apher Sci; 2010 Feb; 42(1):83-8. PubMed ID: 20034854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. When O Bites Back: Unrecognized Acute Hemolytic Reaction from Out-of-Group HLA-Compatible Platelet Transfusion.
    Pasion JO; Song LH; McCusker MG; Shimer L; Bryant A; McGann HL; Fontaine MJ
    Ann Clin Lab Sci; 2021 Mar; 51(2):267-270. PubMed ID: 33941569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfusion efficacy of ABO major-mismatched platelets (PLTs) in children is inferior to that of ABO-identical PLTs.
    Julmy F; Ammann RA; Taleghani BM; Fontana S; Hirt A; Leibundgut K
    Transfusion; 2009 Jan; 49(1):21-33. PubMed ID: 18774963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABO and platelet transfusion revisited.
    Heal JM; Rowe JM; Blumberg N
    Ann Hematol; 1993 Jun; 66(6):309-14. PubMed ID: 8318561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ABO-incompatible platelets are associated with increased transfusion reaction rates.
    Malvik N; Leon J; Schlueter AJ; Wu C; Knudson CM
    Transfusion; 2020 Feb; 60(2):285-293. PubMed ID: 31912889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of crossmatching, HLA, and ABO matching for platelet transfusions to refractory patients.
    Heal JM; Blumberg N; Masel D
    Blood; 1987 Jul; 70(1):23-30. PubMed ID: 3474041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal management with crossmatch-compatible platelets for refractory patients: alloimmunization, response to transfusion, and clinical outcomes (CME).
    Wiita AP; Nambiar A
    Transfusion; 2012 Oct; 52(10):2146-54. PubMed ID: 23113654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How do I implement an automated screen for high-titer ABO antibody as an inventory management tool for ABO plasma-incompatible platelets?
    Fontaine MJ; Webster J; Gomez S; Pham TD; Goodnough LT; Galel SA
    Transfusion; 2015 Dec; 55(12):2783-9. PubMed ID: 26448376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors affecting platelet yield and their impact on the platelet increment of patients receiving single donor PLT transfusion.
    Enein AA; Hussein EA; El Shafie S; Hallouda M
    J Clin Apher; 2007 Feb; 22(1):5-9. PubMed ID: 17266120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet dose consistency and its effect on the number of platelet transfusions for support of thrombocytopenia: an analysis of the SPRINT trial of platelets photochemically treated with amotosalen HCl and ultraviolet A light.
    Murphy S; Snyder E; Cable R; Slichter SJ; Strauss RG; McCullough J; Lin JS; Corash L; Conlan MG;
    Transfusion; 2006 Jan; 46(1):24-33. PubMed ID: 16398727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A flow cytometric platelet immunofluorescence crossmatch for predicting successful HLA matched platelet transfusions.
    Sintnicolaas K; Löwenberg B
    Br J Haematol; 1996 Mar; 92(4):1005-10. PubMed ID: 8616059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. False-negative solid-phase platelet crossmatch results due to prozone phenomenon.
    Horton RK; Zuccarelli MD; Wakefield LL; DiGuardo MA; Gandhi MJ; Juskewitch JE
    Transfusion; 2020 Dec; 60(12):3055-3059. PubMed ID: 33047855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet transfusion - the art and science of compromise.
    Cid J; Harm SK; Yazer MH
    Transfus Med Hemother; 2013 Jun; 40(3):160-71. PubMed ID: 23922541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute hemolytic transfusion reaction following ABO-mismatched platelet transfusion: Two case reports.
    Zulkeflee RH; Hassan MN; Hassan R; Saidin NIS; Zulkafli Z; Ramli M; Abdullah M; Iberahim S; Roslan W; Mohd Noor NH; Wan Ab Rahman WS
    Transfus Apher Sci; 2023 Jun; 62(3):103658. PubMed ID: 36805153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.